This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Journal of Investigative Dermatology | |
|---|---|
| Title | Journal of Investigative Dermatology |
| Discipline | Dermatology |
| Abbreviation | JID |
| Publisher | Elsevier |
| Country | United States |
| Frequency | Monthly |
| History | 1938–present |
| Impact | 8.0 |
| Impact-year | 2024 |
Journal of Investigative Dermatology is a peer-reviewed monthly medical journal publishing research on skin biology, cutaneous immunology, and clinical dermatology. It serves as a forum for investigators from institutions such as Harvard University, Stanford University, National Institutes of Health, Mayo Clinic, and University of California, San Francisco and communicates findings relevant to practitioners affiliated with organizations like the American Academy of Dermatology and the European Academy of Dermatology and Venereology. The journal interfaces with translational research communities at centers such as Johns Hopkins University, University of Pennsylvania, Yale University, Columbia University, and University of Michigan.
Established in 1938, the journal emerged amid professionalization efforts by entities including the American Dermatological Association and the American Academy of Dermatology and paralleled developments at institutions like Massachusetts General Hospital and Bellevue Hospital. Early editors collaborated with investigators from University College London, King's College London, Karolinska Institutet, and University of Tokyo to expand cutaneous research. During the postwar period the journal chronicled advances tied to laboratories such as Rockefeller University, Cold Spring Harbor Laboratory, and Salk Institute and reflected methodological shifts influenced by conferences at Cold Spring Harbor and symposia convened by the National Institutes of Health. Over subsequent decades contributions from researchers associated with Max Planck Society, Institut Pasteur, Weizmann Institute, and University of Toronto shaped its direction.
The journal emphasizes basic science and translational studies conducted at centers such as Broad Institute, Wellcome Trust Sanger Institute, Fred Hutchinson Cancer Research Center, and Dana-Farber Cancer Institute. Topics include molecular pathways investigated at laboratories like Ludwig Institute for Cancer Research, genetic studies performed in collaboration with groups at NHGRI and clinical trials registered with entities such as the Food and Drug Administration and the European Medicines Agency. Work often intersects with disease-focused programs at St. Jude Children's Research Hospital, Mount Sinai Health System, Cleveland Clinic, and Seattle Children's Research Institute and draws on techniques developed at facilities like EMBL-EBI and Broad Institute.
Published monthly by Elsevier on behalf of professional societies similar to the Society for Investigative Dermatology, the journal distributes print and electronic issues via platforms used by libraries at Library of Congress, British Library, National Library of Medicine, and university systems including Oxford University and University of Cambridge. Archival digitization efforts involve partnerships like those between JSTOR, PubMed Central, and institutional repositories at Harvard Library and MIT Libraries. Subscription and open access policies reflect negotiations with consortia such as Project DEAL and funding agencies like the National Institutes of Health and the Wellcome Trust.
The editorial leadership has included scholars with affiliations across Columbia University, University of California, Los Angeles, University of Chicago, Imperial College London, and McGill University. Peer review is conducted by specialists from hospitals and universities including Hospital for Special Surgery, Rothschild Foundation, Guy's and St Thomas' NHS Foundation Trust, and research institutes such as Institut Curie and Babraham Institute. Editorial policies align with best practices advocated by organizations like the Committee on Publication Ethics and reporting guidelines developed by groups including CONSORT and PRISMA when applicable.
The journal is indexed in major bibliographic services and databases used by researchers at National Center for Biotechnology Information, Scopus, Web of Science, and Embase. Library cataloging records exist in systems maintained by OCLC and national bibliographies such as those of the Library of Congress and the British Library. Citation metrics reported by providers including Clarivate, Elsevier, and Google Scholar inform institutional assessments at universities like Princeton University, Cornell University, and University of California, Berkeley.
Citations to articles published in the journal influence clinical guidelines issued by bodies such as the American Academy of Dermatology, the European Academy of Dermatology and Venereology, and advisory committees within the World Health Organization. The journal's work has been discussed at meetings like the annual conferences of the Society for Investigative Dermatology and plenaries at American Association for Cancer Research and Federation of American Societies for Experimental Biology. Recognition for influential contributions has come via awards from institutions such as the National Institutes of Health and prizes conferred at symposia hosted by Royal Society-affiliated organizations.
Landmark articles published in the journal have reported breakthroughs related to pathogenesis and therapy from investigators working at Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Vanderbilt University Medical Center, University of Pittsburgh Medical Center, and King's College London. Notable topics include discoveries in melanocyte biology connected to teams at Salk Institute and Ludwig Institute for Cancer Research, immunotherapy insights linked to research at MD Anderson Cancer Center and Institute of Cancer Research, and genetic findings emerging from collaborations with the 1000 Genomes Project and International HapMap Project. Contributions have influenced drug development programs at pharmaceutical companies and regulatory reviews involving Pfizer, Novartis, Roche, and Johnson & Johnson.
Category:Dermatology journals